Concepedia

Dafeng Sheng

DS

Statistics

Publications

1

Citations

21

H-Index

1

Active since

2020

Affiliations

Shantou Central Hospital(Current)

Dafeng Sheng is an author at Shantou Central Hospital specializing in endometrial cancer, molecular oncology, and cancer bioinformatics.

Publications per year

2020–2020

1

Publications

1

Steroid 5 alpha-reductase 3 (SRD5A3) promotes tumor growth and predicts poor survival of human hepatocellular carcinoma (HCC)

Qicong Mai, Dafeng Sheng, Chengcong Chen et al. · Aging · 2020 · 21 citations · Full text

, , +15

1–1 of 1